BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38368815)

  • 1. Prevalence of trauma history and symptoms in patients who have received vaginal brachytherapy as part of their endometrial cancer treatment.
    Saripalli AL; Ross DH; Murphy E; Gomez K; Thilges S; Harkenrider MM
    Gynecol Oncol; 2024 Jun; 185():68-74. PubMed ID: 38368815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
    Small W; Erickson B; Kwakwa F
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients?
    Nieto K; Martin B; Pham N; Palmere L; Silva SR; Winder A; Liotta M; Potkul RK; Small W; Harkenrider MM
    Brachytherapy; 2018; 17(6):929-934. PubMed ID: 30227976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcome of Exclusively Radiographer-led Delivery of Postoperative Vaginal Vault Brachytherapy for Endometrial Cancer - The Addenbrooke's Experience.
    Buckley H; Bradshaw K; Gregory D; Prewett S; Tan LT
    Clin Oncol (R Coll Radiol); 2019 Dec; 31(12):844-849. PubMed ID: 31307862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies?
    Dohopolski MJ; Horne ZD; Gebhardt BJ; Glaser SM; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Berger JL; Sukumvanich P; Beriwal S
    Brachytherapy; 2018; 17(3):564-570. PubMed ID: 29426745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of vaginal cuff brachytherapy in endometrial cancer.
    Harkenrider MM; Block AM; Siddiqui ZA; Small W
    Gynecol Oncol; 2015 Feb; 136(2):365-72. PubMed ID: 25555710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes in international federation of gynecology and obstetrics stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal brachytherapy.
    Diavolitsis V; Rademaker A; Lurain J; Hoekstra A; Strauss J; Small W
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):415-9. PubMed ID: 22365625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.
    Harkenrider MM; Block AM; Alektiar KM; Gaffney DK; Jones E; Klopp A; Viswanathan AN; Small W
    Brachytherapy; 2017; 16(1):95-108. PubMed ID: 27260082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-institutional Analysis of Vaginal Brachytherapy Alone for Women With Stage II Endometrial Carcinoma.
    Harkenrider MM; Martin B; Nieto K; Small C; Aref I; Bergman D; Chundury A; Elshaikh MA; Gaffney D; Jhingran A; Lee L; Paydar I; Ra K; Schwarz J; Thorpe C; Viswanathan AN; Small W
    Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1069-1077. PubMed ID: 29885996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society.
    Harkenrider MM; Grover S; Erickson BA; Viswanathan AN; Small C; Kliethermes S; Small W
    Brachytherapy; 2016; 15(1):23-9. PubMed ID: 26620818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal brachytherapy for endometrial cancer.
    Hass P; Seinsch S; Eggemann H; Ignatov T; Seitz S; Ignatov A
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1523-1530. PubMed ID: 29730776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of decreasing the fraction number in vaginal cuff brachytherapy: A direct cost analysis.
    Zhang Y; Rovirosa A; Ascaso C; Herreros A; Torne A; Li Y; Biete A; Sánchez J
    Brachytherapy; 2020; 19(1):60-65. PubMed ID: 31587986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
    Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
    Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
    Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Chemotherapy and Vaginal Vault Brachytherapy With or Without Pelvic Radiotherapy for Stage 1 Papillary Serous or Clear Cell Endometrial Cancer.
    Tétreault-Laflamme A; Nguyen-Huynh TV; Carrier JF; Samouëlian V; Sauthier P; Beauchemin MC; Barkati M
    Int J Gynecol Cancer; 2016 Feb; 26(2):301-6. PubMed ID: 26745699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes of early-stage endometrial cancer patients: A propensity score matching of vaginal brachytherapy versus pelvic radiotherapy.
    Petsuksiri J; Setakornnukul J; Berpan A; Thephamongkhol K; Dankulchai P; Jaishuen A
    J Obstet Gynaecol Res; 2023 Dec; 49(12):2918-2928. PubMed ID: 37786395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data.
    Nout RA; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Stenfert Kroese MC; Nijman HW; van de Poll-Franse LV; Creutzberg CL
    Eur J Cancer; 2012 Jul; 48(11):1638-48. PubMed ID: 22176868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.
    Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
    BMC Cancer; 2022 Mar; 22(1):266. PubMed ID: 35287626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study to assess sexual function, quality of life (QOL) and change in vaginal dimensions following vaginal brachytherapy (VBT).
    Nieto K; Levine B; Brown D; Lanier C; Carriere P; McGinnis H; Hines K; Greven K
    Brachytherapy; 2022; 21(3):283-290. PubMed ID: 35123890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.